Otoimmune
1 known investors
Find your way into Otoimmune
Sign up to see every warm intro you have to Otoimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Otoimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OtoImmune is developing precision immunology products under its mOI and mOI Health brands. The page provides no further detail about the specific products, technology, or target customers.
Founders & leadership
JM

Jason MelladFounderCo-founder and CEO of OtoImmune, a precision immunology company. Mellad has spent over two decades working in biotech and life sciences, advancing from research roles to executive positions.
DR

Daniel RookeFounderDaniel Rooke is co-founder and COO of OtoImmune, which develops precision immunology products including mOI Health, an MHRA-registered medical device for immune health testing. He spent over 17 years in law, life sciences, and healthcare, including roles as senior lawyer, general counsel at a rare disease biotech, and co-founder of Start Codon, an early-stage venture builder and fund.
Investors · 1
Frequently asked questions
- What does Otoimmune do?
- OtoImmune is developing precision immunology products under its mOI and mOI Health brands. The page provides no further detail about the specific products, technology, or target customers.
- Who founded Otoimmune?
- Otoimmune was founded by Jason Mellad, Daniel Rooke.
- Who are Otoimmune's investors?
- Otoimmune's investors include AlbionVC.
